SundrugLtd
Market Cap
US$350.7b
Last Updated
2019/07/19 00:21 UTC
Data Sources
Company Financials +
Executive Summary
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan.
Snowflake
Fundamentals
Flawless balance sheet average dividend payer.
Share Price & News
How has SundrugLtd's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
0%
OTCPK:SDGC.F
0.7%
US Consumer Retailing
-0.3%
US Market
1 Year Return
n/a
OTCPK:SDGC.F
17.8%
US Consumer Retailing
3.9%
US Market
No trading data on SDGC.F.
No trading data on SDGC.F.
Share holder returns
| SDGC.F | Industry | Market | |
|---|---|---|---|
| 7 Day | 0% | 0.7% | -0.3% |
| 30 Day | 6.2% | 4.2% | 2.3% |
| 90 Day | n/a | 8.7% | 2.3% |
| 1 Year | n/a | 20.0%17.8% | 6.2%3.9% |
| 3 Year | n/a | 39.1%30.2% | 46.4%36.7% |
| 5 Year | n/a | 59.2%42.1% | 59.6%41.8% |
Price Volatility Vs. Market
How volatile is SundrugLtd's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is SundrugLtd undervalued based on future cash flows and its price relative to the stock market?
24%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
SundrugLtd's share price is below the future cash flow value, and at a moderate discount (> 20%).
SundrugLtd's share price is below the future cash flow value, but not at a substantial discount (< 40%).
Price Based on Earnings
SundrugLtd is good value based on earnings compared to the US Consumer Retailing industry average.
SundrugLtd is good value based on earnings compared to the United States of America market.
Price Based on Expected Growth
SundrugLtd is poor value based on expected growth next year.
Price Based on Value of Assets
SundrugLtd is overvalued based on assets compared to the US Consumer Retailing industry average.
Next Steps
Future Growth
How is SundrugLtd expected to perform in the next 1 to 3 years based on estimates from 6 analysts?
3.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
SundrugLtd's revenue is expected to grow by 4.6% yearly, however this is not considered high growth (20% yearly).
SundrugLtd's earnings are expected to grow by 3.6% yearly, however this is not considered high growth (20% yearly).
SundrugLtd's revenue growth is positive but not above the United States of America market average.
SundrugLtd's earnings growth is positive but not above the United States of America market average.
SundrugLtd's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
SundrugLtd is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Next Steps
Past Performance
How has SundrugLtd performed over the past 5 years?
10.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
SundrugLtd's year on year earnings growth rate has been positive over the past 5 years.
SundrugLtd's 1-year earnings growth is negative, it can't be compared to the 5-year average.
SundrugLtd's 1-year earnings growth is negative, it can't be compared to the US Consumer Retailing industry average.
Return on Equity
SundrugLtd has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
SundrugLtd used its assets more efficiently than the US Consumer Retailing industry average last year based on Return on Assets.
Return on Capital Employed
SundrugLtd's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is SundrugLtd's financial position?
Financial Position Analysis
SundrugLtd is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
SundrugLtd's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
SundrugLtd has no debt.
SundrugLtd has no debt compared to 5 years ago when it was 0.6%.
SundrugLtd has no debt, it does not need to be covered by operating cash flow.
SundrugLtd has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
High level of physical assets or inventory.
SundrugLtd has no debt, it does not need to be covered by short term assets.
Next Steps
Dividend
What is SundrugLtd's current dividend yield, its reliability and sustainability?
2.40%
Expected Dividend Yield
Dividend Yield and Payments Analysis
SundrugLtd's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.43%).
SundrugLtd's dividend is below the markets top 25% of dividend payers in United States of America (3.76%).
Dividends per share have been stable in the past 10 years.
Dividends per share have increased over the past 10 years.
Current Payout to Shareholders
Dividends paid are well covered by earnings (3.1x coverage).
Future Payout to Shareholders
Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
Next Steps
Management
What is the CEO of SundrugLtd's salary, the management and board of directors tenure and is there insider trading?
5.9yrs
Average management tenure
CEO
Akao Kimiya (54yo)
5.9yrs
Tenure
Mr. Akao Kimiya has been the President of Sundrug Co., Ltd since August 2013 and serves as its General Manager of Business Administration. Mr. Kimiya served as the General Manager of Administrative Divisi ...
Management Age and Tenure
5.9yrs
Average Tenure
54yo
Average Age
The average tenure for the SundrugLtd management team is over 5 years, this suggests they are a seasoned and experienced team.
Board Age and Tenure
9.1yrs
Average Tenure
54.5yo
Average Age
The tenure for the SundrugLtd board of directors is about average.
Insider Trading
No 3 month individual insider trading information.
Ownership Breakdown
Management Team
Tsuruta Kazuhiro (54yo)
Chief of Office of President
- Tenure: 5.9yrs
Akao Kimiya (54yo)
President
- Tenure: 5.9yrs
Sakai Yoshimitsu (55yo)
Manager of Store Development Department & Director
- Tenure: 14.3yrs
Board Members
Takashi Tada (50yo)
Director
Sakai Yoshimitsu (55yo)
Manager of Store Development Department & Director
- Tenure: 9.1yrs
Tsuruta Kazuhiro (54yo)
Chief of Office of President
- Tenure: 19.1yrs
Kenji Fujiwara (73yo)
External Director
- Tenure: 4.1yrs
Akao Kimiya (54yo)
President
- Tenure: 17.1yrs
Sadakata Hiroshi (49yo)
Director
- Tenure: 11.1yrs
Saitsu Tatsuro (71yo)
Chairman of the Board
- Tenure: 5.9yrs
- Compensation: ¥130.00m
Ozawa Tetsuro (61yo)
External Auditor
- Tenure: 7.1yrs
Nobuhiko Sugiura (53yo)
External Director
- Tenure: 5.1yrs
Tada Naoki (57yo)
Director
- Tenure: 18.1yrs
Company Information
Sundrug Co.,Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Sundrug Co.,Ltd.
- Ticker: SDGC.F
- Exchange: OTCPK
- Founded: 1957
- Industry: drug retail
- Sector: consumer retailing
- Market Cap: JP¥350.700b
- Listing Market Cap: JP¥3.254b
- Shares outstanding: 116.90m
- Website: Click here
Number of Employees
Location
- Sundrug Co.,Ltd.
- 1-38-1 Wakamatsu-machi
- Fuchu
- Tokyo
- 183-0005
- Japan
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 9989 | TSE (The Tokyo Stock Exchange) | Yes | Common Shares | JP | JPY | Aug 1994 |
| SDGC.F | OTCPK (Pink Sheets LLC) | Yes | Common Shares | US | USD | Aug 1994 |
Biography
Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores. The company was founded in 1957 and is headquartered in Fuchu, Japan.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/07/19 00:21 |
| End of Day Share Price | 2019/06/28 00:00 |
| Earnings | 2019/03/31 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.